Health In Tech (HIT) director granted 18,867 vested restricted shares

Rhea-AI Filing Summary

Shrestha Sanjay K reported acquisition or exercise transactions in this Form 4 filing.

Health In Tech, Inc. director Sanjay K. Shrestha received a grant of 18,867 restricted shares of Class A Common Stock on July 8, 2026 under the Health in Tech Equity Incentive Plan. The restricted stock vested as of the grant date, and his direct holdings increased to 101,200 shares following this award.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Shrestha Sanjay K

Role null

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	18,867	$1.06	$20K

Holdings After Transaction: Class A Common Stock — 101,200 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted shares granted: 18,867 shares Grant price per share: $1.06 per share Shares held after transaction: 101,200 shares

3 metrics

Restricted shares granted 18,867 shares Restricted Class A Common Stock granted on July 8, 2026

Grant price per share $1.06 per share Reported transaction price for the restricted stock award

Shares held after transaction 101,200 shares Total direct Class A Common Stock held by Sanjay K. Shrestha after the award

Key Terms

restricted shares, Health in Tech Equity Incentive Plan, Class A Common Stock

3 terms

restricted shares financial

"Represents restricted shares of Class A Common Stock granted to the reporting person"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Health in Tech Equity Incentive Plan financial

"granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan"

Class A Common Stock financial

"Represents restricted shares of Class A Common Stock granted to the reporting person"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/10/2026 - 06:46 PM Accepted by SEC EDGAR 07/10/2026 - 06:46 PM Learn about SEC filing dates

FAQ

What did Health In Tech (HIT) disclose about Sanjay K. Shrestha in this Form 4?

Health In Tech reported that director Sanjay K. Shrestha received a grant of 18,867 restricted shares of Class A Common Stock, which vested as of the grant date under the company’s equity incentive plan.

How many Health In Tech (HIT) shares does Sanjay K. Shrestha hold after this transaction?

After the award, Sanjay K. Shrestha directly holds 101,200 shares of Health In Tech Class A Common Stock, as reported in the Form 4 following the restricted stock grant.

What type of transaction did Health In Tech (HIT) report for Sanjay K. Shrestha?

The company reported an “A” code transaction, described as a grant, award, or other acquisition of non-derivative Class A Common Stock, rather than an open-market purchase or sale.

At what price was the restricted stock grant to Sanjay K. Shrestha reported by HIT?

The Form 4 lists the restricted stock grant of 18,867 shares with a transaction price of $1.06 per share, reflecting the value used for reporting the equity award.

Did the restricted shares granted to Sanjay K. Shrestha by HIT vest immediately?

Yes. A footnote states the restricted shares vested as of their grant date, meaning the entire 18,867-share award became fully vested when granted under the Equity Incentive Plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shrestha Sanjay K

(Last) (First) (Middle)

701 S. COLORADO AVE

SUITE 1

(Street)

STUART FLORIDA 34994

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	07/08/2026		A		18,867(1)	A	$1.06	101,200	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Sanjay Shrestha	07/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)